Clinical Report: Hepatitis C RNA in 15 Minutes?

Overview

A rapid, automated point-of-care molecular test for hepatitis C RNA using the DASH® Rapid PCR System has been developed and validated. This test delivers results in approximately 15 minutes, potentially streamlining the diagnostic process and reducing patient loss to follow-up.

Background

Hepatitis C virus (HCV) infection remains a significant public health issue despite effective treatments. Traditional diagnostic pathways involve multiple steps, leading to delays in confirming active infections. Rapid testing at the point of care (POC) could facilitate timely diagnosis and treatment, aligning with global health goals for HCV elimination.

Data Highlights

Key Findings

• The DASH® HCV test is a qualitative RT-qPCR assay that provides results in about 15 minutes.
• It has a detection limit of 200 IU/mL and can detect HCV genotypes 1 through 6.
• The assay showed 100% positive and negative agreement compared to established laboratory RNA assays.
• No cross-reactivity was observed with other bloodborne pathogens such as HIV and hepatitis B.
• Rapid POC testing could enable confirmation of active HCV infection during a single clinical visit.

Clinical Implications

The introduction of rapid molecular POC testing for HCV could significantly improve patient management by reducing the time to diagnosis and treatment initiation. This is particularly beneficial in settings with limited access to centralized laboratories.

Conclusion

The DASH® Rapid PCR System represents a promising advancement in HCV diagnostics, potentially enhancing the efficiency of the diagnostic pathway and supporting public health efforts to eliminate HCV.

References

1. The Journal of Infectious Diseases, 2023 -- Rapid Hepatitis C Virus RNA Testing at the Point of Care Achieves 15-Minute Results
2. The Journal of Infectious Diseases, 2023 -- Creation of a Quick Automated Point-of-Care Test for Hepatitis C Viral RNA Utilizing the DASH Rapid PCR System
3. the pathologist, 2023 -- Is Point-of-Care Hepatitis C Virus Testing Too Expensive?
4. Open Forum Infectious Diseases — Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject Drugs
5. WHO Consolidated Guidance on Hepatitis B and C
6. Performance Evaluation of the Xpert® HCV test on Fingerstick Blood
7. Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System | The Journal of Infectious Diseases | Oxford Academic